Press Releases
-
CD Formulation Demonstrates Expertise in CAR-T and CAR-NK Cell Development for Drug Delivery Systems
-
Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance
-
Kindeva Drug Delivery Appoints Brian Schubmehl as Chief Human Resources Officer
Kindeva Drug Delivery (Kindeva), a premier global drug delivery device contract development and manufacturing organization (CDMO), announced that Brian Schubmehl has joined the company as Chief Human Resources Officer.
Sep 14, 2023
-
Huateng Pharma to Attend CPHI Barcelona 2023
Huateng Pharma will be attending CPhI Worldwide, Booth 3C02, Hall 3.
Sep 14, 2023
-
SMi Systems secures UK patent for breakthrough single molecule imaging capabilities
SMi Systems has secured a patent from the UK Intellectual Property Office for the single-molecule imaging technologies that underpin its super-resolution multi-omic platform.
Sep 13, 2023
-
Invitation to learn from the best: Evening of insights and networking will honor a clinical data management stalwart
Invitation to learn from the best: Evening of insights and networking will honor a clinical data management stalwart Prof Deborah Ashby to give the 2023 Sally Hollis Memorial Lecture in Macclesfield
Sep 12, 2023
-
Belong.Life Launches New Conversational AI SaaS Solution for Cancer Clinical Trial Matching and Recruitment
Tara is a SaaS-based conversational AI cancer clinical trial matching platform for health providers and contract research organizations (CROs). The solution is designed to accelerate the process of matching patients with eligible clinical trials, enabling increased recruitment at significantly lower costs. Tara is the second product in Belong’s AI Health Mentor suite of solutions.
Sep 12, 2023
-
Torx® Software announces global drug discovery collaboration with CDD Vault®
Torx® Software Limited has launched a major international collaboration with CDD Vault, which will create a shared digital ecosystem for drug discovery data
Sep 12, 2023
-
Launch of high-quality (pre-clinical) enzymes suitable for pre-clinical and process development in mRNA vaccine and therapeutics
Takara Bio Europe has announced the launch of new high-quality grade mRNA production enzymes suitable for pre-clinical and process development in mRNA vaccine and therapeutic manufacturing.
Sep 11, 2023
-
Tower continues innovation streak with new product launch at CPHI Barcelona
Temperature-controlled container specialist, Tower Cold Chain will be exhibiting its latest concept and products at the world’s largest pharmaceutical event, CPHI.
Sep 10, 2023
-
BioIVT Completes XenoTech Integration, Highlights Expanded ADME-Tox Research Services at the North American ISSX Meeting
BioIVT has implemented new tiered ‘fit-for-purpose’ study designs for metabolism, drug-drug interaction, and transporter programs.
Sep 6, 2023
-
New Educational Initiative, Clinical Trials For All, to Drive More Understanding, Participation, and Diversity
-
Amerigo Scientific Releases FSB Solution Products to Expedite Alzheimer’s Disease Research
-
iotaSciences and Quantum Design China Enter into Distribution Agreement
iotaSciences and Quantum Design China announced today an exclusive distribution agreement for iotaSciences proprietary single cell handling platforms in China.
Sep 5, 2023
-
Dr. Vince Clinical Research Announces First Dosing in Cingulate Therapeutics’ CTx-1301 Phase III Laboratory Classroom Study in ADHD Patients
Dr. Vince Clinical Research (DVCR), a full-service clinical research organization (CRO), today announced the first dosing in Cingulate Therapeutics’ CTx-1301 Phase III dose-optimization onset and duration laboratory classroom study.
Sep 5, 2023
-
Recipharm partners with Ahead Therapeutics to develop rare autoimmune disease therapy
About Recipharm Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical and biopharmaceutical industry employing almost 9,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical and biologics product development, and development and manufacturing of medical devices. Recipharm manufactures several hundred different products for customers ranging from big pharma to smaller research and development companies. The company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK, and the US and is headquartered in Stockholm, Sweden. For more information on Recipharm and our services, please visit www.recipharm.com About Ahead Therapeutics Ahead Therapeutics is a start-up biotech company that uses proprietary technology to develop treatments for different autoimmune disorders. Ahead Therapeutics has developed an innovative solution based on the use of PS-liposomes containing autoantigens. These liposomes can induce antigen-specific immune tolerance through a biomimetic process, thereby interrupting the autoimmune reaction. Simply by changing the encapsulated autoantigen, Ahead’s technology can address the treatment of different auto-immune diseases: Type 1 Diabetes; Multiple Sclerosis; and Celiac Diseases, among others. For more information, please visit www.aheadtherapeutics.com Recipharm AB Corporate identity number 556498-8425 Address Box 603, SE-101 32 Stockholm, Sweden, Telephone +46 8 602 52 00 www.recipharm.com
Sep 4, 2023
-
GenNext Unveils the World’s First Fully Automated Protein Footprinting System at the California Separation Science Society Meeting
GenNext Technologies, Inc. has announced the release of the AutoFox Protein Footprinting System at the California Separation Science Society combined Mass Spectrometry and Higher Order Structure meetings.
Sep 5, 2023
-
GenNext & SCIEX to Co-Market an Advanced High Order Structure Analysis (HOS) Workflow for Biopharmaceutical Research
GenNext Technologies, Inc. has revealed their agreement to co-market a robust, full-solution workflow for Hydroxyl Radical Protein Footprinting studies with SCIEX.
Sep 5, 2023
-
Blue Spark Technologies Adds Amir Lahav to Key Opinion Leader Advisory Group
Blue Spark Technologies, Inc., a leader in wearable remote patient monitoring solutions, has added Amir Lahav, a clinical leader and established neuroscientist with 20 years of experience to its advisory board.
Aug 28, 2023
-
CD Genomics Revolutionizes Pathogen Discovery with the Launch of Viral Metagenomic Sequencing Service